Categories: CLABSI, Healthcare-associated infections, NHSN
February 8th, 2012 11:16 am ET -
.
Daniel Pollock, MD
Author: Dan Pollock
CDC, Division of Healthcare Quality Promotion, Surveillance Branch Chief
CMS announced today that its Hospital Compare website now includes central line-associated bloodstream infection (CLABSI) data reported from hospital ICUs to CDC’s National Healthcare Safety Network (NHSN). In many places, this is the first time consumers can see how well their local hospitals prevent CLABSIs, one of the most deadly and preventable healthcare-associated infections (HAIs).
These data reflect hospital performance during the first quarter of 2011. In many cases, there was not enough data to produce a valid score for a specific hospital. As new data are added each quarter to Hospital Compare, enough information will be available to report accurate measures for more hospitals. A view of statewide progress is also available, based on data from hospitals that participate in CMS’s Value-Based Purchasing program.
Consumers are encouraged to research their local hospitals on Hospital Compare and use the information as a discussion point with their healthcare providers. The information should not be used as the sole factor in choice of hospital.
3 Comments -
Read more
Categories: Antimicrobial Resistance, BSIs, CLABSI, Gram negatives, Healthcare-associated infections, Hemodialysis, MRSA, NHSN
March 2nd, 2011 4:07 pm ET -
.
Arjun Srinivasan, MD
Author – Arjun Srinivasan, MD
CDC’s Division of Healthcare Quality Promotion
As you know, bloodstream infections in patients with central lines can be deadly, killing as many as 1 in 4 patients who gets them. The newest edition of the CDC Vital Signs reports a major decrease in central-line associated bloodstream infections (CLABSIs) in intensive care unit (ICU) patients. This is an important triumph for patient safety and brings me a renewed sense of hope toward the elimination of HAIs. It also solidifies an expectation that infection prevention should be a priority in order to improve the safety of patients.
While progress is promising, about 60,000 bloodstream infections in patients with central lines still occurred outside of ICUs and in dialysis centers, according to our report. Much of this is preventable harm. We have to make every effort to ensure patients are protected in all healthcare facilities, all the time. So, how do we do that?
The good news is that everyone can contribute to preventing CLABSIs, no matter where the patient receives care.
4 Comments -
Read more
Categories: Antimicrobial Resistance, BSIs, CLABSI, Healthcare-associated infections, Hemodialysis, MRSA, NHSN
March 2nd, 2011 1:15 pm ET -
.
Dr. Peter Pronovost on CDC’s Vital Signs Report: Why Success was Possible
Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch
Transcript: Why was success possible?
Success was possible because many groups partnered and worked collaboratively.
On the national level, the CDC, AHRQ, CMS, and Health and Human Services all worked together.
At the state level, state hospital associations, state health departments and quality improvement organizations united forces.
And within hospitals, ICU clinicians, infection preventionists, and hospital managers worked together.
1 Comment -
Read more
Categories: Antimicrobial Resistance, BSIs, CLABSI, Healthcare-associated infections, Hemodialysis, MRSA, NHSN
March 2nd, 2011 1:08 pm ET -
.
Dr. Peter Pronovost on CDC’s Vital Signs Report: How we can work together to leverage our success
Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch.
Transcript: How we can work together to leverage our success
So what can we do:
“US government – work together to mature the science and develop safety programs – programs with clear evidence for best practices, programs with measures that clinicians believe are valid, programs that deliver results, programs that help clinicians believe they can truly make a difference.
States – coordinate efforts, create infrastructure to implement the science, provide technical support to hospitals seeking to measure and reduce infections, and ensure that all hospitals that have not eliminated CLABSI participate in the national program called On the CUSP: Stop BSI.
1 Comment -
Read more
Categories: Antimicrobial Resistance, BSIs, CLABSI, Healthcare-associated infections, Hemodialysis, MRSA, NHSN
March 2nd, 2011 12:59 pm ET -
.
Dr. Peter Pronovost on CDC’s Vital Signs Report: Where do we go from here?
Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch.
Transcript: Where do we go from here?
“We must ensure that all patients in ICUs receive best practices. We have seen dramatic reductions in infections in all types of ICUs – teaching and community, large and small, urban and rural. Yet the results are patchy. Some ICUs remain with high CLABSI rates.
We must apply these lessons to reduce other types of preventable harm such as ventilator-associated pneumonia.
1 Comment -
Read more
